BCL2L1 and neoplasm: Mechanistic studies have elucidated IL-4’s interaction with its receptor, IL4-Rα, triggering upregulation of key anti-apoptotic mediators such as cFLIP, PED, FLAME-1, and Bcl-x(L), thereby facilitating tumor survival and advancement [54,60,61,62].